Target intelligence / Profile preview

TOMM22 pseudogene 4 (TOMM22P4)

Target
TOMM22P4
Molecular classification
Pseudogene
01

Overview

TOMM22 pseudogene 4 (TOMM22P4) is classified as a pseudogene, specifically related to the TOMM22 gene, which encodes the mitochondrial import receptor subunit TOM22. Pseudogenes are segments of DNA that resemble genes but are generally non-functional; they do not produce functional proteins due to mutations or loss of regulatory elements. TOMM22P4 itself does not encode an active protein product and is not considered a molecular target for therapeutic intervention, nor is it known to play a role in biological functions or diseases directly. Key details and justification: - TOMM22P4 is specifically identified as a pseudogene. - Pseudogenes are not conventional drug targets (such as receptors or enzymes) and are typically not associated with pharmacological mechanism or clinical disease association. - The related functional gene, TOMM22, codes for a protein that is part of a mitochondrial translocase complex, but TOMM22P4 does not produce a functional protein. - No evidence or database entries suggest that TOMM22P4 is involved in drug interactions, disease pathogenesis, or biomarker applications. - The entry is "incorrect" as a drug target because it is a non-coding pseudogene, not a conventional molecular target suitable for therapeutic modulation.

Other names
translocase of outer mitochondrial membrane 22 homolog pseudogene 4TOMM22P4

Beyond the preview

Go deeper on TOMM22 pseudogene 4 (TOMM22P4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TOMM22 pseudogene 4 (TOMM22P4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call